Open Medicine
(Apr 2020)
NF2 inhibits proliferation and cancer stemness in breast cancer
Wang Zhibao,
Zhou Zhiqiang,
Wang Zhe,
Cui Yijie
Affiliations
Wang Zhibao
Department of Radiology, The No.2 Hospital of Baoding, No. 338 Dongfeng West Road, Jingxiu District, BaoDing071051, P.R.China
Zhou Zhiqiang
Department of Radiology, The No.2 Hospital of Baoding, No. 338 Dongfeng West Road, Jingxiu District, BaoDing071051, P.R.China
Wang Zhe
Department of Radiology, The No.2 Hospital of Baoding, No. 338 Dongfeng West Road, Jingxiu District, BaoDing071051, P.R.China
Cui Yijie
Department of Radiology, The No.2 Hospital of Baoding, No. 338 Dongfeng West Road, Jingxiu District, BaoDing071051, P.R.China
DOI
https://doi.org/10.1515/med-2020-0042
Journal volume & issue
Vol. 15,
no. 1
pp.
302
– 308
Abstract
Read online
Previous studies have shown that NF2 plays a key role in tumorigenesis. NF2 has been illustrated to be downregulated in several types of human cancer. However, the role of NF2 in breast cancer remains unclear.
Keywords
WeChat QR code
Close